CLINICAL_TRIALS
trial_result
· 2018-05-16
Clinical Trial Update: Vectibix for the Treatment of Anal Cancer [Phase 2]
Summary
Phase 2 clinical trial update showing completion of Vectibix (panitumumab) for anal squamous cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Anal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED